# GEM05 for Patients With Multiple Myeloma Under 65 Years

> **NCT00461747** · PHASE3 · COMPLETED · sponsor: **PETHEMA Foundation** · enrollment: 390 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** VBMCP/VBAD/Velcade
- **DRUG:** Thalidomide/Dexamethasone
- **DRUG:** Velcade/Thalidomide/Dexamethasone

## Key facts

- **NCT ID:** NCT00461747
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 390 (ESTIMATED)
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461747, "GEM05 for Patients With Multiple Myeloma Under 65 Years". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00461747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*